CABA
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
137.2M
75 days until earnings call
KYTX
Price
$3.70
Change
+$0.01 (+0.27%)
Updated
Aug 28 closing price
Capitalization
160.01M
75 days until earnings call
Interact to see
Advertisement

CABA vs KYTX

Header iconCABA vs KYTX Comparison
Open Charts CABA vs KYTXBanner chart's image
Cabaletta Bio
Price$1.50
Change-$0.00 (-0.00%)
Volume$867.6K
Capitalization137.2M
Kyverna Therapeutics
Price$3.70
Change+$0.01 (+0.27%)
Volume$164.24K
Capitalization160.01M
CABA vs KYTX Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. KYTX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Buy and KYTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CABA: $1.50 vs. KYTX: $3.70)
Brand notoriety: CABA and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 59% vs. KYTX: 38%
Market capitalization -- CABA: $137.2M vs. KYTX: $160.01M
CABA [@Biotechnology] is valued at $137.2M. KYTX’s [@Biotechnology] market capitalization is $160.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while KYTX’s TA Score has 6 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 6 bearish.
  • KYTX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, KYTX is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а -6.25% price change this week, while KYTX (@Biotechnology) price change was +3.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

KYTX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($160M) has a higher market cap than CABA($137M). KYTX YTD gains are higher at: -1.070 vs. CABA (-33.921). CABA has higher annual earnings (EBITDA): -140.83M vs. KYTX (-156.46M). KYTX has more cash in the bank: 212M vs. CABA (195M). KYTX has less debt than CABA: KYTX (5.92M) vs CABA (24.9M). CABA (0) and KYTX (0) have equivalent revenues.
CABAKYTXCABA / KYTX
Capitalization137M160M86%
EBITDA-140.83M-156.46M90%
Gain YTD-33.921-1.0703,172%
P/E RatioN/AN/A-
Revenue00-
Total Cash195M212M92%
Total Debt24.9M5.92M421%
FUNDAMENTALS RATINGS
CABA: Fundamental Ratings
CABA
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAKYTX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPHRF0.030.01
+20.05%
OPHIR METALS CORP.
MDIBY24.510.43
+1.78%
MedioBanca SpA
OSBK42.050.45
+1.08%
Oconee Financial Corp.
FLIDY6.07N/A
N/A
FLSmidth & Co. A/S
SEMUF30.00N/A
N/A
Siem Industries, Inc.

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
N/A
IPSC - CABA
52%
Loosely correlated
-2.91%
ARWR - CABA
48%
Loosely correlated
+2.52%
GBIO - CABA
47%
Loosely correlated
-2.83%
KYTX - CABA
45%
Loosely correlated
+0.27%
ARCT - CABA
45%
Loosely correlated
+0.06%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+0.27%
IPSC - KYTX
49%
Loosely correlated
-2.91%
CABA - KYTX
46%
Loosely correlated
N/A
ABOS - KYTX
46%
Loosely correlated
-5.76%
IMNM - KYTX
44%
Loosely correlated
-0.50%
MGNX - KYTX
43%
Loosely correlated
-1.16%
More